The aim of this study is to assess the prevalence and molecular characterization of the extended spectrum b-lactamases (ESBL)-producing Klebsiella pneumoniae isolated from community acquired urinary tract infections and collected in five Moroccan cities during a 2010 survey. In all, 34 (7.5%) of the 453 K. pneumoniae isolates studied were positive for an ESBL phenotype and 91.1% of these isolates were multidrug resistant. The bla CTX-M-15 (n ¼ 31) was the most frequent ESBL genes detected, followed equally by bla SHV-28 and bla SHV-12 (n ¼ 3), then bla TEM-3 , bla SHV-36 , bla SHV-110 and bla CTX-M-1 with one isolate for each (n ¼ 1). Eight isolates co-expressed more than one ESBL with bla CTX-M-15 . The non-ESBL genes detected were bla SHV-1 , bla SHV-11 , bla SHV-32 , bla SHV-26 , bla SHV-76 , bla TEM-1 , bla TEM-1b and bla OXA-1 . Plasmid-mediated AmpC b-lactamase genes, bla ACT-2 , bla DHA-1 and a new b-lacatamase named bla EBC-1464 , were detected in 11.7% of isolates. Fourteen (41.1%) isolates harbored qnr genes; qnrA6 (n ¼ 1), qnrB1 (n ¼ 8), qnrB2 (n ¼ 1) and qnrS1 (n ¼ 4) types were detected. Twenty-six isolates (76.4%) were positive for aac(6 0 )-Ib-cr gene. Results of conjugation experiments indicated that bla CTX-M-15 , bla TEM-1b , bla OXA-1 , aac(6 0 )-Ib-cr and qnrB1 genes were co-transferred and that these genes were carried by a conjugative plasmid of high molecular weight. With the exception of qnrB1, all the antibiotic resistance genes were clustered in a 12-kb region. The results of this work report the genetic diversity of ESBL genes, with the CTX-M-15 enzyme being most common among ESBL-producing K. pneumoniae in Moroccan community. Furthermore, a major finding is that bla EBC-1464 detection is a first in Morocco.
INTRODUCTION
Urinary tract infections (UTIs) remain the common infections diagnosed in outpatients, as well as in hospitalized patients. 1 Escherichia coli and Klebsiella pneumoniae have been reported as the most common organisms causing UTIs. 2 Furthermore, K. pneumoniae is an important pathogen both in the community and the hospital setting to cause severe infections. 3 During the last decade, extended spectrum b-lactamases (ESBLs) type have emerged in the community setting among K. pneumoniae isolates, on plasmids that frequently bear additional resistance determinants. The class A ESBLs, TEM, SHV and CTX-M types, are the most widespread and clinically relevant. TEM and SHV types are derived from penicillinases TEM-1, TEM-2 and SHV-1 and are characterized by several single amino-acid substitutions. These mutations allow them to hydrolyze extended spectrum cephalosporins. More than 200 TEM enzymes and more than 160 different mutants of SHV have been reported (www.lahey.org/Studies/). The plasmid-encoded CTX-M family members, which confer high levels of resistance to extended spectrum cephalosporins, have emerged in several continents around the world. More than 130 different variants of CTX-M enzymes are currently known (www.lahey.org/Studies/). The genes encoding these b-lactamases are often located on large plasmids that also encode genes for resistance to other antibiotics. 4 Furthermore, there is an increasing tendency for pathogens to produce multiple blactamases. 5 ESBL producing Enterobacteriaceae strains, predominated by E. coli and K. pneumoniae, have been isolated from different hospitals in Morocco. 6, 7 The b-lactamase genes detected in Moroccan hospitals isolates were bla TEM , bla SHV , bla DHA and bla OXA types. 6, 8 Recently, bla OXA-48 carbapenemase gene has been detected in one K. pneumoniae isolate in Rabat city. 4 Here, we report the prevalence of ESBL producing K. pneumoniae isolated from UTIs in Moroccan community and the characterization of their b-lactamases enzymes. Current knowledge on antimicrobial susceptibility pattern of this uropathogen is mandatory for appropriate therapy, so the accumulation of other resistance genes by isolates was also investigated.
MATERIALS AND METHODS

Bacterial isolates
A total of 453 non-duplicate community acquired uropathogenic K. pneumoniae isolated from urine specimens (corresponding to an overall incidence in UTIs of 17%) were examined in this study. They were collected from January to December 2010 from medical analysis laboratories of five Moroccan cities: Casablanca situated in the center of Atlantic Coast of Morocco; El Jadida located 100 km south west of Casablanca; Settat situated 72 km South of Casablanca; Rabat located 95 km north east of Casablanca and Meknes located 230 km north east of Casablanca.
The K. pneumoniae isolated from hospitalized or previous hospitalized patients during the study year were excluded. Strains were named (Kpp (K. pneumoniae)) and numbered independently from isolation date.
Antimicrobial drug susceptibility testing
Antimicrobial drug susceptibility was determined by the disk-diffusion method on Mueller-Hinton (MH) agar plates (Bio-Rad, Marnes-la-Coquette, France) as recommended by the French Society for Microbiology (FSM; 2009) (http:// www.sfm-microbiologie.org). The following antimicrobial agents (Bio-Rad) were tested: amoxicillin (10 mg), amoxicillin/clavulanic acid (20/10 mg), cefoxitin (30 mg), cefotaxime (30 mg), ceftazidime (30 mg), cefepime (30 mg), imipenem (10 mg), aztreonam (30 mg), nalidixic acid (30 mg), ciprofloxacin (5 mg), gentamicin (10 mg), tobramycin (10 mg), kanamycin (30 mg), amikacin (30 mg), trimethoprim/sulfamethoxazole (1.25/23.75 mg), trimethoprim (5 mg) and tetracycline (30 mg). Multidrug resistance (MDR) was defined as those resistant to at least two of the antibiotic classes in addition to the b-lactams. E. coli ATCC 25922 was used as quality control strain.
ESBL production was detected by the double-disc synergy test (DDST) using clavulanic acid-amoxicillin (20/10 mg) and ceftazidime (30 mg), cefotaxime (30 mg), aztreonam (30 mg) and cefepime (30 mg) on MH agar as recommended by the FSM (2009) (http://www.sfm-microbiologie.org). Isolates showing a DDST-negative and resistant to third generation cephalosporins were screened for ESBL phenotype; ESBL þ AmpC screening identification kit (Rosco Diagnostica, Taastrup, Denmark) that included antibiotic impregnated tablets: cefotaxime 30 mg, cefotaxime 30 mg þ clavulanate, cefotaxime 30 mg þ cloxacillin, cefotaxime 30 mg þ cloxacillin þ clavulanate were used. By measuring differences in zone of inhibition, they were categorized into strains that produced ESBL or AmpC or both according to the manufacturer's instructions.
Preparation of DNA template for PCR
DNA templates for PCR process were generated by suspending five colonies of an overnight culture of K. pneumoniae isolates growing on Luria Bertani agar (Bio-Rad) in 500 ml of DNase-and RNase-free water (Invitrogen, Paisley, UK). The suspension was boiled at 100 1C for 10 min in thermal block (Polystat 5; Bioblock Scientific, France), and then centrifuged at 19 000 g for 5 min. An aliquot of 1 ml of the supernatant was used as DNA template for PCR.
Identification of phylogenetic groups
The identification of phylogenetic group affiliation of strains was conducted by gyrA PCR-restriction fragment length polymorphism using restriction enzymes TaqI and HaeIII as previously described. 3 Detection of b-lactamase-encoding genes K. pneumoniae isolates were screened by PCR for the following b-lactamaseencoding genes: bla CTX-M phylogenetic lineage groups 1, 2 and 9, bla TEM , bla SHV , bla OXA-1 , bla PER , bla VEB and bla AmpC as described previously. 9, 10 Detection of plasmid-mediated quinolone resistance genes All ESBL-producing strains were screened by PCR for qnr genes (qnrA, qnrB and qnrS) and aac(6 0 )-Ib-cr gene as described previously. 9 All primers used in this work are shown in Table 1 .
Sequencing of resistance genes
The primers used for resistance gene amplification targeting a region allow the sequencing of the whole coding sequence. Both strands of the purified amplicons were sequenced with a Genetic Analyzer 3130 Â 1 sequencer (Applied Biosystems, Foster City, CA, USA) with the same primers used for PCR amplification. The nucleotide and deduced protein sequences were analyzed with software available over the Internet at the National Center for Biotechnology Information website (see www.ncbi.nlm.nih.gov).
Conjugation experiments and plasmid analysis
Conjugation assays were performed by a broth mating and filter mating methods using azide-resistant (Az R ) mutant of E. coli K 12 J 5 as recipient strain. Transconjugants were selected on the MH agar containing azide (200 mg l À1 ) and cefotaxime (2 mg l À1 ) (Bio-Rad) and incubated for 18-24 h at 37 1C.
When not successful at the first attempt, mating experiments were repeated up to three times.
The putative transconjugants were tested for susceptibility to all antibiotics, as indicated previously, to identify transferable antibiotic resistance determinants. Minimal inhibitory concentrations of b-lactams (amoxicillin, cefotaxime, ceftazidime, cefoxitin and cefepime), quinolones (nalidixic acid, ciprofloxacin), aminoglycosides (gentamicin, kanamycin, amikacin and streptomycin) and tetracycline were determined by agar dilution method according to guidelines of the FSM (2009) (http://www.sfm-microbiologie.org) for ESBLcarrying strains and their transconjugants.
Plasmid DNA extraction from both donor and transconjugants was performed using a Plasmid Midi Prep Kit (Qiagen Ltd, West Sussex, UK) according to manufacturer's instructions. The sizes of plasmids were estimated by electrophoresis on 0.7% agarose using the plasmids from E.coli V517 as the standard markers. 11 
Genetic environment of bla CTX-M
The genetic organization of bla CTX-M genes and the sequencing of the regions surrounding these genes were investigated by PCR. The internal IS26 and ISEcp1 forward primers and the CTX-M reverse consensus primer (MA1 reverse) were used to investigate the promoter regions of the bla CTX-M genes. 12 Primer orf477-IRR matches the alternative ISEcp1 IRR. 13 The plasmid DNA obtained from the transconjugants (K. pneumoniae Kpp.319 and Kpp.20) was used to investigate the flanking regions of the bla CTX-M genes by long PCR technique, partial sequencing of the regions surrounding these genes (Table 1 ) and PCR analysis as described previously. [12] [13] [14] 
RESULTS
Prevalence of extended spectrum b-lactamases producing K. pneumoniae isolates Among the 453 community K. pneumoniae strains responsible for UTIs studied, 34 were ESBL producers, so the overall prevalence was 7.5% (3.7-9.0% depending on the cities) ( Table 2) .
Antimicrobial drug susceptibility Disk-diffusion susceptibility testing indicated high prevalence of resistance to various antimicrobial agents: 91.1% of these isolates were MDR. All strains were resistant to amoxicillin, amoxicillin/ clavulanic acid, cefotaxime, ceftazidime, cefepime and aztreonam. Eight (23.5%) strains were resistant to cefoxitin. Five (14.7%) strains show intermediate level of resistance to imipenem. We observed a substantial level of resistance to quinolones; 28 strains (77.7%) had an intermediate level of resistance or were fully resistant to nalidixic acid, and ciprofloxacin. Of the 34 ESBL-carrying strains, only one was susceptible to nalidixic acid and had intermediate resistance level to ciprofloxacin. Cotrimoxazole and tetracycline resistance was observed in 27 (79.4%) and 31 (91.1%) strains, respectively. Twentynine strains (85.3%) were resistant to at least one of the four aminoglycosides tested. The most frequently observed phenotype profile included resistance to gentamicin, tobramycin and kanamycin (n ¼ 23; 79.3% of the strains) followed by resistance to gentamicin and tobramycin (n ¼ 4; 13.7% of the strains) ( Table 3) .
Phylogenetic types of extended spectrum b-lactamase producing K. pneumoniae In total, 29 (82.3%) isolates were identified as K. pneumoniae phylogenetic group I (KpI), 4 (11.7%) as K. pneumoniae phylogenetic group II (KpII) and 2 (5.8%) as K. pneumoniae phylogenetic group III (KpIII). Oxa-2 GTTAAATTCGACCCCAAGTT Plasmid-mediated quinolone resistance genes Fourteen (41.1%) ESBL-producing K. pneumoniae isolates were positive for qnr genes; qnrA-, qnrB-and qnrS-type alleles were detected in 1 (7.1%), 8 (57.1%) and 4 (28.5%) K. pneumoniae isolates, respectively. These were found to be qnrA6, qnrB1, qnrB2 and qnrS1 alleles by sequencing of PCR products (Table 3) . Interestingly, two isolates carried simultaneously two types of qnr genes: Kpp.303 harbored both qnrB1 þ qnrS1 and Kpp.366 carried both qnrA6 þ qnrS1. Twenty-seven isolates (79.4%) were positive for aac(6 0 )-Ib gene, of which 26 (96% of all) isolates carried the -cr variant. The aac(6 0 )-Ibcr gene was detected in 85.7% (12/14 isolates) of qnr-positive isolates, whereas only 51.8% (14/27 isolates) of qnr-negative isolates harbored this gene.
Transfer of extended spectrum b-lactamase genes by conjugation experiment Transfer of b-lactamase genes was observed for three (Kpp20, Kpp319 and Kpp343) out of six isolates examined. Transfer frequencies ranged from 1.10 6 to 2.10 4 per donor cell. Susceptibility results of the clinical strains and their transconjugants are shown in Table 4 . All transconjugants were resistant to amoxicillin, amoxicillin/clavulanic acid, cefotaxime and ceftazidime. Cefoxitin resistance was transferred in the Tc.343 transconjugant, whereas trimethoprim, tobramycin, gentamicin, kanamycin, streptomycin and tetracycline resistances were cotransferred in the Tc.20 and Tc.319 transconjugants (Table 4) . Kpp.343 isolate transferred successfully bla EBC-1464 gene in E. coli K 12 J 5 recipient strain; this gene is carried by one conjugative plasmid of high molecular weight (150 kb). Analysis of gene of the isolates tested was also located on a plasmid of high molecular weight (125 kb).
The plasmid pK319 of Tc.319 transconjugant strain additionally harbored the following four antibiotic resistance genes: bla OXA-1 , bla TEM-1b, aac(6 0 )-Ib-cr and qnrB1 genes. The plasmid pK20 of Tc.20 transconjugant strain carried bla TEM-1b , bla OXA-1 and aac(6 0 )-Ib-cr.
Exploration of the regions surrounding bla CTX-M genes PCR identified the insertion sequence ISEcp1 upstream of the bla CTX-M gene in 32 strains. The sizes of the PCR products were about 0.4 kb in all isolates except Kpp.443 strain. For this strain, the PCR fragment was about 1.1 kb, suggesting the insertion of an additional DNA fragment. PCR with the IS26-specific primer produced no amplicon. The genetic organization of the bla CTX-M-15 genes has been elucidated in the two host plasmids obtained by conjugation experiments (Tc20 and Tc319), in which bla CTX-M-15 gene transfer was successful. In addition, these transconjugants were characterized by their resistance genes diversity. In the mapping of the 3 0 ends, only the PCR with primers P1A and orf477-IRR worked in all these cases, indicating that both modules terminated at the ISEcp1 IRR within orf477. The bla TEM-1b gene was found to be located in a Tn3-like transposon. The tnpA gene of the Tn3 transposon is disrupted by ISEcp1-bla CTX-M-15 . Long-PCR analysis confirmed that bla CTXM-15 was located just upstream from aac(6 0 )-Ib-cr. With the exception of qnrB in pK.319, all the antibiotic resistance genes were clustered in a 12-kb region.
DISCUSSION
The ESBL producing K. pneumoniae isolates are increasingly causing UTIs both in hospitalized and outpatients. 1, [15] [16] The prevalence of ESBL producing isolates of K. pneumoniae varies in different countries. In European hospitals, it ranges from as low as 5% in Iceland and Estonia to as high as 59.3 to 100% in Ireland, Spain, Germany, Bulgaria and Romania. [16] [17] However, there is limited data regarding the prevalence of ESBLs producing K. pneumonia in community. In the present study, 34 of the 453 (7.5%) K. pneumoniae isolates were ESBL producers. Higher rates of ESBL production among community-onset bacteremic UTIs caused by E. coli and K. pneumoniae have been reported from Taiwan (17.9%) and Scotland (12.5%). 3, 5 KpI is the most prevalent phylogenetic group in K. pneumoniae isolates from Moroccan community as reported in previous studies. 3, 15 These preliminary results should be expanded by pulsed field gel electrophoresis or multilocus sequence typing methods to determine epidemiologic relationships among isolates.
ESBL-producing K. pneumoniae are commonly resistant to different antibiotic families, which contributes to the selection and persistence of MDR-ESBL strains and plasmids in community settings, resulting in the limitation of therapeutic options. [18] [19] [20] In this study, the rate of MDR was alarmingly high (91.1%), imipenem being the most active among the antibiotics tested. All these observations indicate the real threat of this problem, particularly when we know that the increasing use of carbapenems that have been widely used to treat serious infections with MDR K. pneumoniae, has led to the emergence of carbapenem-resistant isolates via acquired genes encoding carbapenem-hydrolyzing enzymes. 20 ESBLs CTX-M types have been known for their rapid spread in African and European communities. 3, 9, [21] [22] The first detection of bla CTX-M (CTX-M-15 and CTX-M-28) in Morocco was documented in 2010 at the teaching hospital Ibn Rochd in Casablanca. 6 In a previous study, we have investigated, for the first time, the dissemination of these enzymes among community ESBL producing Enterobacteriaceae isolates responsible for UTIs, including a restricted sample of K. pneumoniae strains. 9 To contribute to a better understanding of the epidemiology of (Table 3) , presumably explaining the high percentage of non-susceptibility to amoxicillin-clavulanic acid. This genes combination has been found in the same strain in Portugal. 21 The bla CTX-M-15 plus bla OXA-1 plus bla TEM-1 or bla TEM-1b was coexpressed by 23 strains. This genes association has been also reported in strains from Portugal. 21 However, the combination of bla CTX-M-15 plus bla TEM-3 reported here is, to our knowledge, first in Africa. Twenty-nine ESBL-producing K. pneumoniae isolates carried bla SHV , of which, twenty-three encoded non-ESBL types. It is noteworthy that this study reported the detection of SHV-28, SHV-36 and -110-producing isolates for the first time in Morocco. Plasmid analysis revealed that the transconjugants (Tc.20 and Tc.319) harbored large plasmids of about 125 kb and these plasmids (pK.319 and pK.20) carry only two known resistance genes, bla TEM-1b and bla CTX-M-15 . These findings suggest that the CTX-M-15 allele is carried on large conjugative plasmids that are well adapted and constantly exchanged by lateral gene transfer among the K. pneumoniae isolates. Previous studies have shown that bla TEM genes are carried by three of the earliest described bacterial transposons, namely Tn1, Tn2 and Tn3. These transposons contain the transposase and resolvase genes, tnpA and tnpR, as well as a resolution site. 23 The bla TEM-1 gene was found to be located in a Tn3-like. Interestingly, the tnpA gene of the Tn3 transposon is disrupted by ISEcp1-bla CTX-M-15 due to ISEcp1-mediated transposition. The mechanism involves the left inverted repeat of ISEcp1 and a right inverted repeat (IRR1), which resembles the IRR of ISEcp1. 24 The resistance of K. pneumoniae to cephamycins have also arisen by acquisition of plasmids containing the chromosomally derived AmpC b-lactamase. 6 In Morocco, the PABLs types previously detected were DHA-1 and CMY-2. 6, 25 In this study, we detected eight cefoxitinresistant K. pneumoniae, of which four isolates harbored PABLs genes. They could become an important cause, in addition to ESBLproducing isolates, of increasing resistance to extended spectrum b-lactams in Moroccan community. The major finding of this study was the report of the occurrence of the ACT-2 b-lactamase for the first time in Morocco. Furthermore, we detected two strains that harbored bla EBC-1464 gene. To the best of our knowledge, this is the second report of EBC-1464 b-lactamase in the world. The EBC-1464 b-lactamase was a novel PABL detected in a K. pneumoniae isolate from China (GenBank: FJ237368.1). Cefoxitin resistance in AmpC non-producers could be due to some other resistance mechanism, such as lack of permeation of porins. 26 In conclusion, our results demonstrate that the resistance of ESBLproducing K. pneumoniae responsible for UTIs to a wide variety of common antimicrobials continue to become a serious global health concern that could complicate treatment strategies. We also report the first detection in Morocco of bla EBC-1464 and the diversity of the b-lactamase genes of community K. pneumoniae isolates, with the CTX-M-15 being most common. To ensure appropriate therapy, current knowledge of antibiotic susceptibility of the organisms that cause UTIs is mandatory. 1 In this context, routine screening for ESBLs producers in the laboratory is of great importance for their early identification and management.
